Large-Joint Reconstructive Implants Market Global Report 2026

The large-joint reconstructive implants market size has grown rapidly in recent years. It will grow from $11.7 billion in 2025 to $12.88 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to the rising global prevalence of degenerative joint disorders like osteoarthritis and rheumatoid arthritis, an expanding geriatric demographic prone to bone wear and tear, increasing volumes of primary hip and knee arthroplasty, growing sports-related joint injuries, and the expansion of specialized orthopedic hospital infrastructure.

The large-joint reconstructive implants market size is expected to see strong growth in the next few years. It will grow to $18.65 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to the rapid adoption of minimally invasive orthopedic procedures, rising clinical preference for cementless press-fit implants, expanding healthcare infrastructure and medical tourism in emerging markets, growing cases of joint degeneration linked to rising obesity rates, and favorable public and private insurance reimbursement frameworks for orthopedic surgeries. Major trends in the forecast period include the widespread integration of AI and robotic-assisted surgical systems for precise component placement, the expansion of patient-specific, 3D-printed custom implants that mirror individual anatomy, the development of highly durable advanced biomaterials (such as cross-linked polyethylene and ceramic coatings) to extend implant longevity, a shifting volume of uncomplicated surgeries toward Ambulatory Surgical Centers (ASCs), and a rising demand for specialized revision implants to address early hardware failures.

The increasing prevalence of obesity is anticipated to drive the growth of the large-joint reconstructive implants market in the coming years. Obesity is a long-term medical condition that can lead to musculoskeletal complications and gradual deterioration of joints. The growing obesity burden is primarily attributed to higher intake of processed foods that are rich in calories. Large-joint reconstructive implants provide an effective solution for managing obesity-associated joint-related complications by replacing damaged joints and enhancing patients’ mobility and quality of life. For example, in March 2024, according to the Organization for Economic Co-operation and Development, a France-based intergovernmental organization, 60% of adults aged 15 years and above across 13 OECD countries were classified as overweight or obese in 2023, increasing from approximately 56% in the previous year. Hence, the rising prevalence of obesity is contributing to the expansion of the large-joint reconstructive implants market.

Leading companies operating in the large-joint reconstructive implants market are focusing on developing advanced solutions, such as robotic-assisted orthopedic surgery systems, to improve implant positioning accuracy, reduce surgical variability, and support faster patient recovery. Robotic-assisted orthopedic surgery systems refer to advanced surgical platforms that utilize robotic arms, real-time imaging, and data-driven surgical planning tools to assist surgeons during joint replacement procedures with enhanced precision and consistency. For example, in March 2025, Stryker Corporation, a US-based medical technology company, introduced the fourth-generation Mako 4 SmartRobotics platform and expanded its Mako Total Hip application with Advanced Primary and Revision capabilities. The platform offers three-dimensional computed tomography-based surgical planning, intraoperative screw trajectory guidance, augment and screw planning features, and compatibility with Stryker’s revision hip implant portfolio to support improved workflow efficiency and accuracy in hip and joint reconstruction procedures.

In March 2024, Stryker Corporation, a US-based manufacturer of orthopedic implants, acquired SERF SAS for an undisclosed sum. Through this acquisition, Stryker sought to reinforce its large-joint reconstruction implant portfolio by broadening its hip replacement product range and strengthening its footprint in the European orthopedic implant market by leveraging SERF SAS's advanced dual mobility hip implant technologies. SERF SAS is a France-based company that manufactures large-joint reconstruction implants, including hip and knee reconstruction implant solutions.

Major companies operating in the large-joint reconstructive implants market report are Stryker Corporation, B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Arthrex Inc., Enovis Corporation, CONMED Corporation, Medacta International SA, Exactech Inc., Corin Group, MicroPort Orthopedics Inc., United Orthopedic Corporation, Ortho Development Corporation, Baumer S.A., Sharma Orthopedic India Pvt. Ltd., Peter Brehm GmbH, GPC Medical Ltd., XLO India Limited, ImplanTec GmbH, Beznoska s.r.o., HEMC Ortho, Waldemar Link GmbH & Co. KG.

North America was the dominating region in the large-joint reconstructive implants market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the large-joint reconstructive implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the large-joint reconstructive implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.